Ezetimibe and simvastatin vs DAPTOmycin

Interacting Drugs
Ezetimibe and simvastatin
vs
DAPTOmycin
Security Level
Moderate, Consider therapy modification
Mechanism
DAPTOmycin: HMG-CoA Reductase Inhibitors may enhance the adverse/toxic effect of DAPTOmycin. Specifically, the risk of skeletal muscle toxicity may be increased.
Management
Consider temporarily stopping HMG-CoA reductase inhibitor therapy prior to daptomycin. If used together, regular (i.e., at least weekly) monitoring of CPK concentrations is recommended.

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Ezetimibe and simvastatin vs DAPTOmycin


Other Interactions of Ezetimibe and simvastatin

We are Developing Our database, More results coming soon.